MROPF
Price
$0.13
Change
-$0.20 (-60.61%)
Updated
Sep 25 closing price
Capitalization
695.4M
NXL
Price
$1.20
Change
+$0.11 (+10.09%)
Updated
Jul 21 closing price
Capitalization
13.84M
43 days until earnings call
Interact to see
Advertisement

MROPF vs NXL

Header iconMROPF vs NXL Comparison
Open Charts MROPF vs NXLBanner chart's image
MICROPORT CARDIOFLOW MEDTECH
Price$0.13
Change-$0.20 (-60.61%)
Volume$100
Capitalization695.4M
Nexalin Technology
Price$1.20
Change+$0.11 (+10.09%)
Volume$267.36K
Capitalization13.84M
MROPF vs NXL Comparison Chart in %
Loading...
NXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MROPF vs. NXL commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MROPF is a Hold and NXL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (MROPF: $0.13 vs. NXL: $1.20)
Brand notoriety: MROPF and NXL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MROPF: 100% vs. NXL: 265%
Market capitalization -- MROPF: $695.4M vs. NXL: $13.84M
MROPF [@Medical Specialties] is valued at $695.4M. NXL’s [@Medical Specialties] market capitalization is $13.84M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MROPF’s FA Score shows that 1 FA rating(s) are green whileNXL’s FA Score has 0 green FA rating(s).

  • MROPF’s FA Score: 1 green, 4 red.
  • NXL’s FA Score: 0 green, 5 red.
According to our system of comparison, both MROPF and NXL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NXL’s TA Score shows that 5 TA indicator(s) are bullish.

  • NXL’s TA Score: 5 bullish, 4 bearish.

Price Growth

MROPF (@Medical Specialties) experienced а 0.00% price change this week, while NXL (@Medical Specialties) price change was +16.50% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.79%. For the same industry, the average monthly price growth was +3.54%, and the average quarterly price growth was -2.04%.

Reported Earning Dates

NXL is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Medical Specialties (+0.79% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MROPF($695M) has a higher market cap than NXL($13.8M). MROPF YTD gains are higher at: 0.000 vs. NXL (-56.522). NXL has higher annual earnings (EBITDA): -4.56M vs. MROPF (-118.59M). MROPF has more cash in the bank: 2.21B vs. NXL (3.94M). NXL has less debt than MROPF: NXL (518K) vs MROPF (126M). MROPF has higher revenues than NXL: MROPF (201M) vs NXL (129K).
MROPFNXLMROPF / NXL
Capitalization695M13.8M5,036%
EBITDA-118.59M-4.56M2,600%
Gain YTD0.000-56.522-
P/E RatioN/AN/A-
Revenue201M129K155,814%
Total Cash2.21B3.94M56,185%
Total Debt126M518K24,324%
TECHNICAL ANALYSIS
Technical Analysis
MROPFNXL
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
1%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMWB8.780.21
+2.45%
Similarweb Ltd
RCI33.320.39
+1.18%
Rogers Communications
MTVA0.680.01
+0.92%
MetaVia Inc
SMHI5.21-0.01
-0.19%
SEACOR Marine Holdings
QDEL25.30-0.15
-0.59%
QuidelOrtho Corp

MROPF and

Correlation & Price change

A.I.dvisor tells us that MROPF and MEDP have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MROPF and MEDP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MROPF
1D Price
Change %
MROPF100%
N/A
MEDP - MROPF
26%
Poorly correlated
-0.96%
STSS - MROPF
9%
Poorly correlated
+9.36%
PRE - MROPF
8%
Poorly correlated
+2.09%
OLYMY - MROPF
4%
Poorly correlated
+0.43%
NXL - MROPF
3%
Poorly correlated
+10.09%
More

NXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXL has been loosely correlated with RBOT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NXL jumps, then RBOT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXL
1D Price
Change %
NXL100%
+10.09%
RBOT - NXL
49%
Loosely correlated
-0.29%
BFLY - NXL
27%
Poorly correlated
+0.53%
HYPR - NXL
25%
Poorly correlated
+5.30%
GKOS - NXL
23%
Poorly correlated
-0.99%
RXST - NXL
22%
Poorly correlated
N/A
More